Status:
COMPLETED
Therapeutic Education in Physical Activity (ETAF)
Lead Sponsor:
Azienda USL Reggio Emilia - IRCCS
Collaborating Sponsors:
GRADE Onlus
University of Modena and Reggio Emilia
Conditions:
Hematologic Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To date, studies published on multidimensional rehabilitation programs are addressed to patients with different types of cancer and, frequently, these studies only include a limited number of patients...
Detailed Description
This is a randomized controlled pilot study • Control Group will be offered usual care (UC), which includes two sessions of therapeutic education delivered in small groups. In these educational sessio...
Eligibility Criteria
Inclusion
- First diagnosis of blood cancer or early relapse of blood cancer
Exclusion
- Expected prognosis \<12 months
- Clinical or anamnestic conditions preventing participation in the rehabilitation program (dementia, non-collaboration for major psychiatric disorders, blindness, deafness, any language barriers or communication deficits that prevent participation in the program, etc.)
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 3 2019
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT03403075
Start Date
January 1 2018
End Date
December 3 2019
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Health Authority - IRCCS of Reggio Emilia
Reggio Emilia, RE, Italy, 42123